Who Paid My Doc
Connex 1
Research payments
$1,597,221
Through program year 2025, $1,597,221 in research payments was reported against Connex 1, across 300 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim RCV GmbH & Co KG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $213,218 | 15 |
| 2024 | Research | $790,173 | 40 |
| 2023 | Research | $437,790 | 38 |
| 2022 | Research | $99,409 | 23 |
| 2021 | Research | $56,631 | 184 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Tshekedi Dennis Huntington Beach, CA Named on 20 payments
- Eric Chavez San Diego, CA Named on 19 payments
- Nancy Navarro-Gonzalez Miami, FL Named on 17 payments
- David Brown Austin, TX Named on 17 payments
- Shishuka Malhotra Canton, OH Named on 17 payments
- Francisco Ricart Coral Gables, FL Named on 16 payments
- Diana Ghelber Fort Worth, TX Named on 16 payments
- Suresh Sureddi Plano, TX Named on 15 payments
- Mark Lerman Northbrook, IL Named on 14 payments
- James Knutson Kirkland, WA Named on 13 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.